Luca Ceriani

机构：Ente Ospedaliero Cantonale, Università della Svizzera italiana · ORCID：0000-0002-6371-097X

发表论文 302 篇 · 总被引 5986 次 · h-index 41

代表论文

• Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell Lymphoma: International Metabolic Prognostic Index (2022 · Journal of Clinical Oncology · 被引 163)
• International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline 18 F-FDG PET/CT of Lymphoma Patients: A Milestone Toward Clinical Implementation (2024 · Journal of Nuclear Medicine · 被引 72)
• An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients (2023 · Scientific Reports · 被引 39)
• Baseline PET radiomics outperform the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma (2023 · Blood · 被引 37)
• Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results (2024 · Journal of Clinical Oncology · 被引 33)
• Is thyroglobulin a reliable biomarker of differentiated thyroid cancer in patients treated by lobectomy? A systematic review and meta-analysis (2022 · Clinical Chemistry and Laboratory Medicine (CCLM) · 被引 24)